ID

31183

Description

Study ID: 104505 Clinical Study ID: BEX104505 Study Title: Phase II Study of Iodine 131 Anti B1 Antibody for 1st or 2nd Relapsed Indolent B-Cell Lymphomas or B-Cell Lymphomas That Have Transformed to a More Aggressive Histology Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00950755 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 2 Study Recruitment Status: Completed Generic Name: tositumomab Trade Name: Bexxar Study Indication: Lymphoma, Non-Hodgkin Please record all concomitant medications and transfusions from the time of study entry through the Week 13 visit. Include study-required medications (i.e. Lugol's solution or potassium iodide, paracetamol, and diphenhydramine).

Keywords

  1. 7/25/18 7/25/18 -
Copyright Holder

see clinicaltrials.gov

Uploaded on

July 25, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

Iodine 131 B1 Antibody for B-Cell Lymphomas NCT00950755

Concomitant Medications & Transfusions

Administrative Data
Description

Administrative Data

Alias
UMLS CUI-1
C1320722
Site Number
Description

Site number

Data type

text

Alias
UMLS CUI [1,1]
C0018704
UMLS CUI [1,2]
C0600091
Patient Number
Description

Patient Number

Data type

text

Alias
UMLS CUI [1]
C1830427
Patient Initials
Description

Patient Initials

Data type

text

Alias
UMLS CUI [1]
C2986440
Concomitant Medications; Concomitant Transfusions
Description

Concomitant Medications; Concomitant Transfusions

Alias
UMLS CUI-1
C2347852
Drug Name or Blood Product
Description

Concomitant Agent; Drug Name or Blood Product

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C2360065
UMLS CUI [1,3]
C0456388
Dose
Description

Concomitant Agent; Dose

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3174092
Unit
Description

Concomitant Agent; Unit

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C1519795
Route
Description

Concomitant Agent; Route

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0013153
Frequency
Description

Concomitant Agent; Frequency

Data type

text

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C3476109
Start Date
Description

Concomitant Agent; Start Date

Data type

date

Alias
UMLS CUI [1]
C2826734
End Date
Description

Concomitant Agent; End Date

Data type

date

Alias
UMLS CUI [1]
C2826744

Similar models

Concomitant Medications & Transfusions

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Administrative Data
C1320722 (UMLS CUI-1)
Site number
Item
Site Number
text
C0018704 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
Patient Number
Item
Patient Number
text
C1830427 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Concomitant Medications; Concomitant Transfusions
C2347852 (UMLS CUI-1)
Concomitant Agent; Drug Name or Blood Product
Item
Drug Name or Blood Product
text
C2347852 (UMLS CUI [1,1])
C2360065 (UMLS CUI [1,2])
C0456388 (UMLS CUI [1,3])
Concomitant Agent; Dose
Item
Dose
text
C2347852 (UMLS CUI [1,1])
C3174092 (UMLS CUI [1,2])
Concomitant Agent; Unit
Item
Unit
text
C2347852 (UMLS CUI [1,1])
C1519795 (UMLS CUI [1,2])
Concomitant Agent; Route
Item
Route
text
C2347852 (UMLS CUI [1,1])
C0013153 (UMLS CUI [1,2])
Concomitant Agent; Frequency
Item
Frequency
text
C2347852 (UMLS CUI [1,1])
C3476109 (UMLS CUI [1,2])
Concomitant Agent; Start Date
Item
Start Date
date
C2826734 (UMLS CUI [1])
Concomitant Agent; End Date
Item
End Date
date
C2826744 (UMLS CUI [1])

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial